Continuing therapy in childhood leukaemia
Intended for healthcare professionals
Clinical Previous     Next

Continuing therapy in childhood leukaemia

Anita Cox Macmillan Paediatric Oncology Nurse Specialist, Department of Paediatric Haematology and Oncology, The Royal London Hospital, London

Acute lymphoblastic leukaemia (ALL) is the most common form of childhood cancer and a major part of the treatment protocol involves oral chemotherapy taken as an out-patient. In order to achieve maximum therapy with minimum side effects, each child’s full blood count results are monitored weekly and their drug doses are titrated accordingly. One paediatric regional oncology centre has implemented anew approach to this continuing therapy by transferring the responsibility from medical to nursing staff, with very positive results

Cancer Nursing Practice. 1, 10, 29-32. doi: 10.7748/cnp2002.12.1.10.29.c8098

Correspondence

anitajcox@hotmail.com

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more